Atlas Trials

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

Clinical trial NCT03647072 · RECRUITING

Trial details

NCT number
NCT03647072
Sponsor
Sherief Abd-Elsalam
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma
Start date
2018-08-01
Primary completion
2027-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.